Share & more
Seven Indian generic drugs have been reinstated on the World Health Organisation (WHO) list of approved HIV/AIDS medicines for use in developing countries.
The UN health agency removed three of the drugs from its list in August 2004, and Ranbaxy willingly withdrew the other four drugs shortly after, also citing uncertainty about whether they were biologically the same as the patented drugs.
"Subsequently, WHO ran the full range of quality, safety and efficacy checks on the medicines, as well as thorough inspections of the new laboratories. The products and laboratories were all found to be satisfactory," WHO noted.
According to WHO, Ranbaxy Laboratories had been able to prove that the antiretrovirals were as effective as the patented versions.
This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions